Back to top
more

AdvisorShares Pure Cannabis ETF: (YOLO)

(Delayed Data from NYSE) As of Sep 1, 2026 04:00 PM ET

$3.06 USD

3.06
36,915

-0.05 (-1.61%)

Volume: 36,915

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

Zacks News

Sweta Killa headshot

Cannabis ETFs Set to Soar on Passage of Legalization Bill

Cannabis stocks are poised to surge further especially following the legislation passed by the House to legalize marijuana nationwide.

Sanghamitra Saha headshot

After a Downbeat 2021, Will Marijuana ETFs Rebound in 2022?

Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.

Sanghamitra Saha headshot

Marijuana Secures Top-Performing ETF Spot Last Week

Wall Street was downbeat last week as a strong rally in the main indexes paused due to a high inflation.

Sweta Killa headshot

Cannabis ETFs Soar on Republican-Led Legalization Bill

Cannabis ETFs have gained momentum lately following the reports of a Republican-led bill, which is seeking to legalize marijuana at the federal level in the United States.

Sanghamitra Saha headshot

Cannabis ETFs to Surge on Banking Bill Approval in House

On Apr 19, the U.S. House of Representatives okayed legislation that would allow banks to provide services to cannabis companies in states where it is legal.

Sanghamitra Saha headshot

Cannabis On a Roll: Guide to ETF Investing

Shares of cannabis-related stocks and ETFs continue to be in good shape after a solid run last year.

Neena Mishra headshot

Should You Invest in Marijuana Stocks & ETFs Now?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Sweta Killa headshot

Cannabis ETFs Spike on Jazz-GW Pharma Deal

Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.

Sanghamitra Saha headshot

4 Best Investing Areas of Q4 & Their Top ETFs

Despite yearlong COVID-19 fears, Wall Street is ending the fourth quarter on a sweet note.

Sanghamitra Saha headshot

Top 4 ETF Areas of Last Week

Wall Street came up with a mixed performance last week.